Skip to main content

Table 4 How and when to screen

From: Survey on patients’ organisations’ knowledge and position paper on screening for inherited neuromuscular diseases in Europe

Modality of screening Number of answers When should screening take place? Number of answers
Systematic with the option to opt-out 21 At birth 9
   Early pregnancy 6
   Preconception 4
   Depends on the disease and the situation 3
Systematic 4 At birth 2
   Early pregnancy 1
   Preconception 1
Not systematic with the possibility to opt-in 3 At birth 1
   Depends on the disease and the situation 1
   Preconception 1
\